Repligen (RGEN) Common Equity (2010 - 2026)
Repligen (RGEN) posted quarterly Common Equity of $2.1 billion for Q2 2026, up 2.44% year-over-year from $2.1 billion in Q2 2025, and little changed quarter-over-quarter from $2.1 billion in Q1 2026.
Repligen (RGEN) Common Equity (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported Common Equity for 17 consecutive years, with $2.1 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Common Equity rose 2.44% year-over-year to $2.1 billion; the TTM figure through Jun 2026 stood at $2.1 billion (up 2.44% YoY), while the FY2025 annual figure was $2.1 billion, up 6.76% from the prior year.
- Common Equity held at $2.1 billion in Q2 2026 per RGEN's latest filing, from $2.1 billion in the prior quarter.
- Across five years, Common Equity topped out at $2.1 billion in Q2 2026 and bottomed at $1.8 billion in Q1 2022.
- Historically, Common Equity has averaged $2.0 billion across 5 years, with a median of $2.0 billion in 2023.
- Annual changes were most pronounced in 2022 — Common Equity advanced 13.51% — and 2024, when it increased 0.4%.
- Repligen's Common Equity stood at $1.9 billion in 2022, then grew by 2.83% to $2.0 billion in 2023, then rose by 0.4% to $2.0 billion in 2024, then climbed by 6.76% to $2.1 billion in 2025, then increased by 0.28% to $2.1 billion in 2026.
- Business Quant data shows RGEN's Common Equity at $2.1 billion in Q2 2026, $2.1 billion in Q1 2026, and $2.1 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.30 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 24.42 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 21.60 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 6.59 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 19.08 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.99 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 4.80 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 8.24 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 6.21 Bn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | 2.11 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.11 Bn |
| Mar 31, 2026 | 2.11 Bn |
| Dec 31, 2025 | 2.11 Bn |
| Sep 30, 2025 | 2.08 Bn |
| Jun 30, 2025 | 2.06 Bn |
| Mar 31, 2025 | 1.99 Bn |
| Dec 31, 2024 | 1.97 Bn |
| Sep 30, 2024 | 2.02 Bn |
| Jun 30, 2024 | 1.98 Bn |
| Mar 31, 2024 | 1.97 Bn |
| Dec 31, 2023 | 1.96 Bn |
| Sep 30, 2023 | 1.97 Bn |
| Jun 30, 2023 | 1.96 Bn |
| Mar 31, 2023 | 1.93 Bn |
| Dec 31, 2022 | 1.91 Bn |
| Sep 30, 2022 | 1.84 Bn |
| Jun 30, 2022 | 1.81 Bn |
| Mar 31, 2022 | 1.77 Bn |
| Dec 31, 2021 | 1.75 Bn |
| Sep 30, 2021 | 1.72 Bn |